Amphastar Pharmaceuticals Surges, Analysts Cautiously Optimistic

Amphastar Pharmaceuticals shares surged by 3.7% in afternoon trading, driven by positive analyst ratings and favorable technical indicators. The average price target set by analysts is $32 per share, suggesting potential growth. Insider activity and the stocks position above key moving averages also boosted sentiment. However, the stock closed at $27.55, down 24.2% year-to-date and 38.7% below its 52-week high. Despite recent fluctuations, a $1000 investment five years ago would now be worth approximately $1486.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.